Research indicates that it may help lower blood pressure, cholesterol levels, and improve blood vessel function, potentially reducing the risk of coronary artery disease
The SURPASS clinical trials involving over 10,000 patients did not identify palpitations as a significant safety signal, with gastrointestinal effects being the most frequently reported adverse reactions
Kaufman-Janette J, Joseph JH, Kaminer MS, Clark J, Fabi SG, Gold MH, Goldman MP, Katz BE, Peddy K, Schlessinger J, Young VL, Davis M, Hurley D, Liu G, McLane MP, Vijayan S, Bass LS
The information presented regarding individual ingredients reflects published research and does not constitute evidence that ColonBroom GLP-1 Booster as a finished product will produce particular outcomes
Expanding oral GLP-1 options could help many patients access effective treatment who might otherwise never start therapy because they dont want injections
It may prove to be completely harmless, or we may start to see problems coming to the surface. Experts are also worried about Lemon Bottles regulatory status
